AirSculpt Technologies, Inc. Advertising Expense
AirSculpt Technologies, Inc. (AIRS) reported Advertising Expense of $8.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2026-08-10
- AirSculpt Technologies, Inc. advertising expense for the quarter ending 2026-06-30 was $8.80M, a 20.55% increase year-over-year.
- AirSculpt Technologies, Inc. advertising expense for the quarter ending 2026-03-31 was $7.80M, a 8.33% increase year-over-year.
- AirSculpt Technologies, Inc. advertising expense for the quarter ending 2025-12-31 was $6.40M, a 9.86% decline year-over-year.
- AirSculpt Technologies, Inc. advertising expense for the quarter ending 2025-09-30 was $6.40M, a 7.25% decline year-over-year.
- AirSculpt Technologies, Inc. advertising expense for fiscal 2025 was $27.30M, a 18.26% decline from fiscal 2024.
- AirSculpt Technologies, Inc. advertising expense for fiscal 2024 was $33.40M, a 28.96% increase from fiscal 2023.
- AirSculpt Technologies, Inc. advertising expense for fiscal 2023 was $25.90M, a 25.73% increase from fiscal 2022.
- AirSculpt Technologies, Inc. advertising expense for fiscal 2022 was $20.60M, a 39.19% increase from fiscal 2021.
| Period end | Advertising Expense 3 month | Advertising Expense 6 month | Advertising Expense 9 month | Advertising Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.80M 10-Q · filed 2026-08-10 | $16.60M 10-Q · filed 2026-08-10 | $23.00M derived: sum of 3 quarters · filed 2026-08-10 | $29.40M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $7.80M 10-Q · filed 2026-05-08 | $14.20M derived: sum of 2 quarters · filed 2026-05-08 | $20.60M derived: sum of 3 quarters · filed 2026-05-08 | $27.90M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $6.40M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | $12.80M derived: sum of 2 quarters · filed 2026-04-06 | $20.10M derived: sum of 3 quarters · filed 2026-08-10 | $27.30M 10-K/A · filed 2026-04-06 |
| 2025-09-30 | $6.40M 10-Q · filed 2025-11-07 | $13.70M derived: sum of 2 quarters · filed 2026-08-10 | $20.90M 10-Q · filed 2025-11-07 | $28.00M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $7.30M 10-Q · filed 2026-08-10 | $14.50M 10-Q · filed 2026-08-10 | $21.60M derived: sum of 3 quarters · filed 2026-08-10 | $28.50M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $7.20M 10-Q · filed 2026-05-08 | $14.30M derived: sum of 2 quarters · filed 2026-05-08 | $21.20M derived: sum of 3 quarters · filed 2026-05-08 | $32.20M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $7.10M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | $14.00M derived: sum of 2 quarters · filed 2026-04-06 | $25.00M derived: sum of 3 quarters · filed 2026-04-06 | $33.40M 10-K/A · filed 2026-04-06 |
| 2024-09-30 | $6.90M 10-Q · filed 2025-11-07 | $17.90M derived: sum of 2 quarters · filed 2025-11-07 | $26.30M 10-Q · filed 2025-11-07 | $32.70M derived: sum of 4 quarters · filed 2026-04-06 |
| 2024-06-30 | $11.00M 10-Q · filed 2025-08-01 | $19.40M 10-Q · filed 2025-08-01 | $25.80M derived: sum of 3 quarters · filed 2026-04-06 | $32.30M derived: sum of 4 quarters · filed 2026-04-06 |
| 2024-03-31 | $8.40M 10-Q · filed 2025-05-02 | $14.80M derived: sum of 2 quarters · filed 2026-04-06 | $21.30M derived: sum of 3 quarters · filed 2026-04-06 | $28.20M derived: sum of 4 quarters · filed 2026-04-06 |
| 2023-12-31 | $6.40M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | $12.90M derived: sum of 2 quarters · filed 2026-04-06 | $19.80M derived: sum of 3 quarters · filed 2026-04-06 | $25.90M 10-K/A · filed 2026-04-06 |
| 2023-09-30 | $6.50M 10-Q · filed 2024-11-08 | $13.40M derived: sum of 2 quarters · filed 2024-11-08 | $19.50M 10-Q · filed 2024-11-08 | $24.70M derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-06-30 | $6.90M 10-Q · filed 2024-08-09 | $12.90M 10-Q · filed 2024-08-09 | $18.20M derived: sum of 3 quarters · filed 2025-03-14 | $23.60M derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-03-31 | $6.10M 10-Q · filed 2024-05-10 | $11.30M derived: sum of 2 quarters · filed 2025-03-14 | $16.70M derived: sum of 3 quarters · filed 2025-03-14 | $21.90M derived: sum of 4 quarters · filed 2025-03-14 |
| 2022-12-31 | $5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $10.60M derived: sum of 2 quarters · filed 2025-03-14 | $15.80M derived: sum of 3 quarters · filed 2025-03-14 | $20.60M 10-K · filed 2025-03-14 |
| 2022-09-30 | $5.40M 10-Q · filed 2023-11-13 | $10.60M derived: sum of 2 quarters · filed 2023-11-13 | $15.40M 10-Q · filed 2023-11-13 | $20.80M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $5.20M 10-Q · filed 2023-08-11 | $10.00M 10-Q · filed 2023-08-11 | $15.40M derived: sum of 3 quarters · filed 2024-02-27 | $19.70M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $4.80M 10-Q · filed 2023-05-12 | $10.20M derived: sum of 2 quarters · filed 2024-02-27 | $14.50M derived: sum of 3 quarters · filed 2024-02-27 | $17.10M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $9.70M derived: sum of 2 quarters · filed 2024-02-27 | $12.30M derived: sum of 3 quarters · filed 2024-02-27 | $14.80M 10-K · filed 2024-02-27 |
| 2021-09-30 | $4.30M 10-Q · filed 2022-11-14 | $6.90M derived: sum of 2 quarters · filed 2022-11-14 | $9.40M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $2.60M 10-Q · filed 2022-08-12 | $5.10M 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $2.50M 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | $7.00M 10-K · filed 2023-03-10 | |||
| 2019-12-31 | $7.20M 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |